Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran
- 21 June 2019
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 42 (12) , 1467-1476
Abstract
Transfusion-dependent beta-thalassemia (TDT) patients suffer from various endocrinopathies. The main contributing factor associated with these complications is iron overload, secondary to frequent blood transfusions. To improve patients’ quality of life, we evaluated the prevalence of endocrine disorders while considering the associated factors for further assessment.Keywords
This publication has 46 references indexed in Scilit:
- Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelinesIndian Journal of Endocrinology and Metabolism, 2013
- Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia majorAnnals of Hematology, 2012
- Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia majorBritish Journal of Haematology, 2010
- Bone Disease in Thalassemia: A Frequent and Still Unresolved ProblemJournal of Bone and Mineral Research, 2009
- Dual Energy X-ray Absorptiometry Interpretation and Reporting in Children and Adolescents: The 2007 ISCD Pediatric Official PositionsJournal of Clinical Densitometry, 2008
- BONE MINERAL DENSITY IN IRANIAN ADOLESCENTS AND YOUNG ADULTS WITH β-THALASSEMIA MAJORPediatric Hematology and Oncology, 2007
- Low Bone Mineral Density in Adolescents with β‐ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugsJournal of Bone and Mineral Metabolism, 2004
- Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic PatientsDiabetes Care, 2001
- Growth Failure and Bony Changes Induced by DeferoxamineJournal of Pediatric Hematology/Oncology, 1992